Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Diluted Weighted Average Shares Outstanding as they would be Anti-Dilutive - shares	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Diluted Weighted Average Shares Outstanding as they would be Anti-Dilutive [Line Items]
Total shares issuable upon exercise or conversion	83,768,509	175,950,509
Stock options [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Diluted Weighted Average Shares Outstanding as they would be Anti-Dilutive [Line Items]
Total shares issuable upon exercise or conversion	988,675	2,790,675
Convertible notes & associated fees [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Diluted Weighted Average Shares Outstanding as they would be Anti-Dilutive [Line Items]
Total shares issuable upon exercise or conversion	80,853,333	171,233,333
Warrants [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Diluted Weighted Average Shares Outstanding as they would be Anti-Dilutive [Line Items]
Total shares issuable upon exercise or conversion	1,926,501	1,926,501

ACTAVIA LIFE SCIENCES, INC. 10-K